Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
AKTIENPREIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionArlington Partners LLC
Latest Disclosed Ownership3,977 shares
Latest Disclosed Value $ 241,205
Arlington Partners LLC ownership in BRM / Bristol-Myers Squibb Company

On April 9, 2026 - Arlington Partners LLC filed a 13F-HR form disclosing ownership of 3,977 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $208,474 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 0 shares of Bristol-Myers Squibb Company. The current value of the position is $188,629 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-09 2026-03-31 13F Bristol-Myers Squibb COM 110122108 3,977 3,977 241 0.4814
2026-01-29 2025-12-31 13F Bristol-Myers Squibb COM 110122108 0 -105,711 -100.00 0 -100.00
2025-10-28 2025-09-30 13F Bristol-Myers Squibb COM 110122108 105,711 10,382 10.89 4,768 8.05 1.6473
2025-07-14 2025-06-30 13F Bristol-Myers Squibb COM 110122108 95,329 14,532 17.99 4,413 -10.45 1.6279
2025-04-23 2025-03-31 13F Bristol-Myers Squibb COM 110122108 80,797 0 0.00 4,928 7.84 1.9337
2025-01-29 2024-12-31 13F Bristol-Myers Squibb COM 110122108 80,797 -10,000 -11.01 4,570 -2.73 1.7742
2024-10-21 2024-09-30 13F Bristol-Myers Squibb COM 110122108 90,797 12,491 15.95 4,698 44.43 1.8376
2024-08-06 2024-06-30 13F/A-1 Bristol-Myers Squibb COM 110122108 78,306 15,773 25.22 3,252 -4.10 1.6147
2024-08-01 2024-06-30 13F Bristol-Myers Squibb COM 110122108 78,306 15,773 3,252 1.6147
2024-04-16 2024-03-31 13F Bristol-Myers Squibb COM 110122108 62,533 60,558 3,066.23 3,391 3,257.43 1.7268
2024-01-24 2023-12-31 13F Bristol-Myers Squibb COM 110122108 1,975 1,975 101 0.0291
2023-10-24 2023-09-30 13F Bristol-Myers Squibb COM 110122108 0 -1,692 -100.00 0 -100.00
2023-07-26 2023-06-30 13F Bristol-Myers Squibb COM 110122108 1,692 -182 -9.71 108 -16.28 0.0167
2023-04-26 2023-03-31 13F Bristol-Myers Squibb COM 110122108 1,874 -317 -14.47 130 -17.83 0.0185
2023-01-24 2022-12-31 13F/A-1 Bristol-Myers Squibb COM 110122108 2,191 404 22.61 158 23.62 0.0250
2023-01-19 2022-12-31 13F Bristol-Myers Squibb COM 110122108 2,191 404 0 0.0250
2022-10-28 2022-09-30 13F Bristol-Myers Squibb COM 110122108 1,787 -172 -8.78 127 -15.89 0.0509
2022-07-25 2022-06-30 13F Bristol-Myers Squibb COM 110122108 1,959 643 48.86 151 57.29 0.0501
2022-04-14 2022-03-31 13F Bristol-Myers Squibb COM 110122108 1,316 74 5.96 96 24.68 0.0272
2022-01-18 2021-12-31 13F Bristol-Myers Squibb COM 110122108 1,242 -1,019 -45.07 77 -42.54 0.0207
2021-10-15 2021-09-30 13F Bristol-Myers Squibb COM 110122108 2,261 1,579 231.52 134 191.30 0.0386
2021-07-07 2021-06-30 13F Bristol-Myers Squibb COM 110122108 682 0 0.00 46 6.98 0.0160
2021-04-19 2021-03-31 13F Bristol-Myers Squibb COM 110122108 682 0 0.00 43 2.38 0.0157
2021-01-13 2020-12-31 13F Bristol-Myers Squibb COM 110122108 682 0 0.00 42 2.44 0.0193
2020-10-15 2020-09-30 13F Bristol-Myers Squibb COM 110122108 682 0 0.00 41 2.50 0.0225
2020-07-13 2020-06-30 13F Bristol-Myers Squibb COM 110122108 682 593 666.29 40 700.00 0.0225
2020-04-13 2020-03-31 13F Bristol-Myers Squibb COM 110122108 89 -400 -81.80 5 -83.87 0.0026
2020-01-16 2019-12-31 13F Bristol-Myers Squibb COM 110122108 489 89 22.25 31 55.00 0.0190
2019-10-18 2019-09-30 13F Bristol-Myers Squibb COM 110122108 400 0 0.00 20 11.11 0.0127
2019-07-10 2019-06-30 13F Bristol-Myers Squibb COM 110122108 400 -1,169 -74.51 18 -76.00 0.0081
2019-04-05 2019-03-31 13F Bristol-Myers Squibb COM 110122108 1,569 169 12.07 75 2.74 0.0536
2019-01-10 2018-12-31 13F Bristol-Myers Squibb COM 110122108 1,400 400 40.00 73 17.74 0.0475
2018-10-23 2018-09-30 13F Bristol-Myers Squibb COM 110122108 1,000 1,000 62 0.0437
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.